A Japanese research team said that it had developed a field test for Ebola that gives results in just over 11 minutes, down from the 90-minute test used until now.
The breakthrough by Nagasaki University's Institute of Tropical Medicine will allow medics to move much more quickly in treating people with the hemorrhagic fever, Professor Jiro Yasuda said. "The result time was unexpectedly short," said Yasuda of the trial conducted in Guinea last month on 100 samples, of which 47 proved positive.
New Quick-Acting Ebola Vaccine Offers Complete Protection with just One Dose
The new Ebola vaccine, Trojan horse, provides a complete, single dose protection from a lethal amount of the Makona strain of the Ebola virus.
Advertisement
The Guinean government has now asked the institute and its collaboration partner Toshiba to supply equipment to roll out the test, he added.
The test hinges on what the researchers have called a "primer", a substance that amplifies only those genes specific to the Ebola virus found in a blood sample or other bodily fluid.
![Phase 1 Clinical Trial of Ebola Vaccine Passes Safety Test, Shows Good Immune Response]( "Phase 1 Clinical Trial of Ebola Vaccine Passes Safety Test, Shows Good Immune Response")
A new study has revealed that an experimental Ebola vaccine called VSV-EBOV appears safe and generates immune response in a small phase 1 clinical trial.
Using existing techniques, ribonucleic acid (RNA) -- biological molecules used in the coding of genes -- is extracted from any viruses present in a sample.
This is then used to synthesize the viral DNA, which can be mixed with the primer and then heated to 60-65 degrees Celsius (140-149 Fahrenheit).
If Ebola is present, DNA specific to the virus is amplified by the action of the primers. The by-products from the process cause the liquid to become cloudy, providing visual confirmation, Yasuda said.
Currently, a method called polymerase chain reaction, or PCR, is used to detect the Ebola virus. This requires doctors to heat and cool samples repeatedly and takes at least 90 minutes, sometimes up to two hours.
The Ebola virus, transmitted through contact with infected bodily fluids, has killed more than 10,000 people in western Africa since it re-emerged in December 2013.
Source: AFP
Phase 1 Clinical Trial of Ebola Vaccine Passes Safety Test, Shows Good Immune Response
A new study has revealed that an experimental Ebola vaccine called VSV-EBOV appears safe and generates immune response in a small phase 1 clinical trial.
Advertisement
Using existing techniques, ribonucleic acid (RNA) -- biological molecules used in the coding of genes -- is extracted from any viruses present in a sample.
This is then used to synthesize the viral DNA, which can be mixed with the primer and then heated to 60-65 degrees Celsius (140-149 Fahrenheit).
If Ebola is present, DNA specific to the virus is amplified by the action of the primers. The by-products from the process cause the liquid to become cloudy, providing visual confirmation, Yasuda said.
Currently, a method called polymerase chain reaction, or PCR, is used to detect the Ebola virus. This requires doctors to heat and cool samples repeatedly and takes at least 90 minutes, sometimes up to two hours.
The Ebola virus, transmitted through contact with infected bodily fluids, has killed more than 10,000 people in western Africa since it re-emerged in December 2013.
Source: AFP
Texas Health Resources Sued Over Lack of Ebola Training Seeks Dismissal of Lawsuit
The company said that the hospital acted responsibly to protect their employees, basing their responses on the most up-to-date federal guidelines.
Advertisement
 Ontario Patient With Symptoms of Ebola Tests Negative at SunnybrookThe patient had returned to Canada from West Africa 10 days earlier and was put into isolation as a precaution when Ebola-like symptoms began to appear. | Advertisement
|
Advertisement
Recommended Reading
Latest Tropical Disease News
Pregnant women in Korogwe, Tanzania are found to have a high risk of contracting malaria, which is one of the deadliest diseases in sub-Saharan Africa.
Can nasal swab test save you from emerging diseases? Yes, simple nasal swab can offer early detection of new deadly viruses.
Brain-eating amoeba (Naegleria fowleri) infection claims a South Korean man's life.
Harmless infrared light is used to detect malaria with the help of a computer algorithm processed by a smart phone.
Monkeypox virus may be shed into semen during both acute and convalescent stages of the disease in crab-eating macaques.